CLADRIBINE

cladribine 10 mg tablet, 6

CLADRIBINE (11611D)

cladribine 10 mg tablet, 6
11611D
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  16345

Indication: Relapsing remitting multiple sclerosis
Treatment phase: Initial treatment

Restriction  16299

Indication: Relapsing remitting multiple sclerosis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 6 # of repeats: 1 DPMQ: $6,893.01 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
CLADRITAB
Mavenclad